Circulating LncRNAs Serve as Diagnostic Markers for Hepatocellular Carcinoma | Zendy

Weidong Yuan | Zendy; Yong Sun | Zendy; Ling Liu | Zendy; Bing Zhou | Zendy; Shuming Wang | Zendy; Gu Dianhua | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Circulating LncRNAs Serve as Diagnostic Markers for Hepatocellular Carcinoma

Author(s) -

Weidong Yuan,

Yong Sun,

Ling Liu,

Bing Zhou,

Shuming Wang,

Gu Dianhua

Publication year - 2017

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000484589

Subject(s) - hepatocellular carcinoma , medicine , diagnostic biomarker , cancer research , oncology , biology , cancer

Circulating (serous or plasmic) long non-coding RNA (lncRNA) as biomarkers for predicting the diagnosis or prognosis of human disease have been well documented. Due to the sensibility or specificity limitation of Alpha Fetoprotein (AFP), a cluster lncRNAs were revealed as fingerprints for hepatocellular carcinoma (HCC). In this study, we enrolled all the reported circulating lncRNAs in HCC as candidate targets and examined in an independent cohort.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research